intracranial bleeding

This nationwide Finnish cohort study evaluates the competing risks of stroke, recurrent intracranial bleeding, and mortality with anticoagulation strategies in atrial fibrillation patients who had prior intracranial bleeding. It highlights the safer profile of DOACs versus warfarin in this high-risk population.